cyclosporine has been researched along with Multiple Sclerosis in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 24 (70.59) | 18.2507 |
| 2000's | 6 (17.65) | 29.6817 |
| 2010's | 2 (5.88) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Oberlies, NH; Pearce, CJ; Strader, CR | 1 |
| Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H | 1 |
| Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K | 1 |
| Hatch, MN; Keirstead, HS; Lane, TE; Schaumburg, CS | 1 |
| Fujita, T; Kohno, T; Tsuji, T; Yoshida, Y | 1 |
| Hirata, Y; Kaneda, K; Kojima, K; Kozuka, T; Manabe, Y; Okuma, S; Takenaka, K; Tanimoto, M; Toki, H | 1 |
| Hartung, HP; Kieseier, BC | 1 |
| Castel, MA; Deutsch, O; Nägele, H; Reichenspurner, H; Wagner, FM | 1 |
| Bradley, EL; Burgard, S; Kachelhofer, RD; Layton, BA; McFarland, HF; Smith, ME; Stone, LA; Whitaker, JN; Williams, PH; Zhao, G | 1 |
| Borel, JF; Chabannes, D; Kovarik, J | 1 |
| Abu-Elmagd, K; Carroll, PB; McCauley, J; Starzl, TE; Thomson, AW; Van Thiel, DH; Woo, J | 1 |
| Liu, HM; Lu, CS | 1 |
| Eshenaur, AE; Hassell, TM; Hefti, AF; Stone, C | 1 |
| Ellison, GW; Ke, D; Leake, BD; Mickey, MR; Myers, LW; Syndulko, K; Tourtellotte, WW | 1 |
| Kastrukoff, L; Koopmans, R; Li, DK; Oger, JJ; Paty, DW; Tanton, E; Zhao, GJ | 1 |
| Hughes, RA | 1 |
| Lowy, MT; Reder, AT | 1 |
| Baskerville, J; Issa, M; Weinshenker, BG | 1 |
| Funaoka, M; Hoshino, T; Ishii, T; Kato, J; Kato, K; Komatsu, M; Kuramitsu, T; Masamune, O; Ono, T; Toyoshima, I | 1 |
| Cover, K; Koopmans, RA; Li, DK; Mietlowski, W; Paty, DW; Redekop, WK; Riddehough, A; Wolinsky, JS; Zhao, GJ | 1 |
| Baumhefner, RW; Ellison, GW; Ke, D; Myers, LW; Syndulko, K; Tourtellotte, WW | 1 |
| Agostini, HT; Baumhefner, RW; Ryschkewitsch, CF; Stoner, GL; Tourtellotte, WW | 1 |
| Khoury, SJ; Weiner, HL | 1 |
| Bakalska, M; Deleva, D; Filchev, N; Zaprianova, E | 1 |
| Brochet, B | 1 |
| Elpern, S; McFarland, H; Roca, CA; Rubinow, DR; Su, TP | 1 |
| Alvarez-Cermeño, JC; Alvarez-Mon, M; de la Piedra, M; Gimeno, A; Guillen, C; Prieto, A | 1 |
| Harness, J; McCombe, PA; Pender, MP | 1 |
| Franklin, RJ; Smith, PM | 1 |
| Medaer, R; Raus, JC; Schreurs, M; Zhang, JW | 1 |
| Grüssinger, A; Knehans, A; Kühn, K; Reichel, H; Ritz, E; Schmidt-Gayk, H | 1 |
| Tindall, RS | 1 |
| Caruso, LS; Foley, FW; LaRocca, NG; Perlman, KR; Scheinberg, LC; Smith, CR; Traugott, U | 1 |
| Borel, JF; Chabannes, D; Ryffel, B | 1 |
9 review(s) available for cyclosporine and Multiple Sclerosis
| Article | Year |
|---|---|
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
Topics: Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Hypocreales; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Sphingosine; Structure-Activity Relationship; United States; United States Food and Drug Administration | 2011 |
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Current disease-modifying therapies in multiple sclerosis.
Topics: Adjuvants, Immunologic; Analgesics; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclophosphamide; Cyclosporine; Glatiramer Acetate; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasma Exchange | 2003 |
FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.
Topics: Adult; Animals; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Cholangitis; Cyclosporine; Diabetes Mellitus, Type 1; Digestive System Diseases; Disease Models, Animal; Drug Evaluation; Drug Evaluation, Preclinical; Female; Humans; Kidney Diseases; Male; Mice; Multiple Sclerosis; Nephrotic Syndrome; Psoriasis; Rats; Swine; Tacrolimus | 1993 |
Immunotherapy for multiple sclerosis.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Female; Forecasting; Humans; Immunotherapy; Interferon-beta; Male; Multiple Sclerosis; Recurrence | 1994 |
Meta-analysis of the placebo-treated groups in clinical trials of progressive MS.
Topics: Autoimmune Diseases; Azathioprine; Brain Stem; Clinical Trials, Phase III as Topic; Cyclosporine; Disease Progression; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Multiple Sclerosis; Placebos; Plasma Exchange; Pyramidal Tracts; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Failure | 1996 |
Multiple sclerosis: what have we learned from magnetic resonance imaging studies?
Topics: Adjuvants, Immunologic; Clinical Trials as Topic; Cognition; Cyclosporine; Gadolinium DTPA; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-alpha; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Prognosis; Psychomotor Performance; Severity of Illness Index; Treatment Outcome | 1998 |
[Non-specific immunosuppression and multiple sclerosis].
Topics: Antibodies, Monoclonal; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphatic Irradiation; Multiple Sclerosis | 1998 |
Immunointervention with cyclosporin A in autoimmune neurological disorders.
Topics: Acrodynia; Amyotrophic Lateral Sclerosis; Autoimmune Diseases; Cyclosporine; Demyelinating Diseases; Humans; Multiple Sclerosis; Myasthenia Gravis; Myositis; Nervous System Diseases; Polyradiculoneuropathy | 1992 |
8 trial(s) available for cyclosporine and Multiple Sclerosis
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosis.
Topics: Adult; Cyclosporine; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Nervous System Diseases; Radioimmunoassay; Reference Values; Sensitivity and Specificity | 1994 |
Gingival overgrowth in cyclosporine A treated multiple sclerosis patients.
Topics: Adolescent; Adult; Chi-Square Distribution; Cyclosporine; Dental Plaque Index; Dose-Response Relationship, Drug; Double-Blind Method; Gingival Hyperplasia; Humans; Logistic Models; Middle Aged; Multiple Sclerosis; Odds Ratio; Periodontal Index; Periodontitis; Reproducibility of Results; Saliva; Sensitivity and Specificity; Statistics, Nonparametric | 1994 |
Serum prolactin levels in active multiple sclerosis and during cyclosporin treatment.
Topics: Adult; Cyclosporine; Double-Blind Method; Female; Humans; Lymphocyte Activation; Male; Multiple Sclerosis; Prolactin | 1993 |
Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis. The MS Study Group.
Topics: Brain; Cohort Studies; Cyclosporine; Disability Evaluation; Double-Blind Method; Drug Monitoring; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis; Neurologic Examination; Treatment Outcome | 1997 |
Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. Reliability, validity and sensitivity to disease progression. Multiple Sclerosis Study Group.
Topics: Activities of Daily Living; Chronic Disease; Cyclosporine; Double-Blind Method; Evaluation Studies as Topic; Humans; Immunosuppressive Agents; Multiple Sclerosis; Neurologic Examination; Psychomotor Performance; Reproducibility of Results; Treatment Outcome | 1996 |
Long-term therapy with cyclosporin A does not influence serum concentrations of vitamin D metabolites in patients with multiple sclerosis.
Topics: Adult; Azathioprine; Calcifediol; Calcitriol; Creatine; Cyclosporine; Double-Blind Method; Female; Humans; Kidney; Male; Multiple Sclerosis; Parathyroid Hormone; Vitamin D | 1992 |
A prospective study of depression and immune dysregulation in multiple sclerosis.
Topics: Adult; Analysis of Variance; CD4-CD8 Ratio; Cyclosporine; Depression; Female; Humans; Immunity; Male; Middle Aged; Multiple Sclerosis; Placebos; Prospective Studies | 1992 |
18 other study(ies) available for cyclosporine and Multiple Sclerosis
| Article | Year |
|---|---|
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult | 2021 |
Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis.
Topics: Animals; Cell Differentiation; Cells, Cultured; Cyclosporine; Disease Models, Animal; Embryonic Stem Cells; Graft Rejection; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Murine hepatitis virus; Myelin Sheath; Oligodendroglia; T-Lymphocytes; Virus Replication | 2009 |
Relapse of experimental autoimmune encephalomyelitis after discontinuation of FTY720 (Fingolimod) treatment, but not after combination of FTY720 and pathogenic autoantigen.
Topics: Animals; Autoantigens; Cyclosporine; Demyelinating Diseases; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Fingolimod Hydrochloride; Glycoproteins; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Nerve Tissue Proteins; Peptide Fragments; Propylene Glycols; Remission Induction; Secondary Prevention; Specific Pathogen-Free Organisms; Sphingosine; Spinal Cord | 2011 |
Autoimmune neutropenia associated with multiple sclerosis.
Topics: Autoimmune Diseases; Cyclosporine; gamma-Globulins; Humans; Immunosuppressive Agents; Leukapheresis; Leukocyte Count; Male; Middle Aged; Multiple Sclerosis; Neutropenia; Neutrophils | 2003 |
Heart transplantation in a patient with multiple sclerosis and mitoxantrone-induced cardiomyopathy.
Topics: Adult; Benzimidazoles; Cardiomyopathies; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Mitoxantrone; Multiple Sclerosis | 2004 |
Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
Topics: Animals; Autoimmune Diseases; Concanavalin A; Corticosterone; Cyclosporine; Dexamethasone; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Furans; Guinea Pigs; Lymph Nodes; Lymphocyte Activation; Lysophosphatidylcholines; Multiple Sclerosis; Myelin Basic Protein; Phospholipid Ethers; Rats; Rats, Inbred Lew; Tuberculin | 1995 |
Magnetic resonance imaging in a multiple sclerosis patient with progressive ataxia.
Topics: Adult; Brain Stem; Cerebellar Ataxia; Cerebellum; Cyclosporine; Female; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 1994 |
Design strategies in multiple sclerosis clinical trials. The Cyclosporine Multiple Sclerosis Study Group.
Topics: Clinical Trials, Phase III as Topic; Cyclosporine; Follow-Up Studies; Humans; Multiple Sclerosis; Neurologic Examination; Recurrence; Research Design; Severity of Illness Index; Survival Analysis; Treatment Outcome | 1994 |
Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis.
Topics: Brain; Clinical Trials as Topic; Cyclosporine; Humans; Interferon-alpha; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Placebos; Sensitivity and Specificity; Severity of Illness Index | 1994 |
Fulminant hepatitis caused by hepatitis C virus during treatment for multiple sclerosis.
Topics: Anti-Inflammatory Agents; Autopsy; Cyclosporine; Fatal Outcome; Female; Glucocorticoids; Hepatic Encephalopathy; Hepatitis C; Humans; Immunosuppressive Agents; Liver; Liver Failure, Acute; Middle Aged; Multiple Sclerosis; Necrosis; Steroids | 1996 |
Characterization of JC virus DNA amplified from urine of chronic progressive multiple sclerosis patients.
Topics: Adult; Amino Acid Sequence; Base Sequence; Case-Control Studies; Chronic Disease; Cyclosporine; Disease Progression; DNA, Viral; Female; Humans; Immunosuppressive Agents; JC Virus; Male; Middle Aged; Molecular Sequence Data; Multiple Sclerosis; Polymerase Chain Reaction | 1996 |
[Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis].
Topics: Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Lumbosacral Region; Multiple Sclerosis; Rats; Rats, Inbred Lew; Rats, Inbred WKY; Recurrence; Spinal Cord | 1997 |
Cerebrospinal fluid somatostatin, mood, and cognition in multiple sclerosis.
Topics: Adult; Affect; Analysis of Variance; Case-Control Studies; Chronic Disease; Clinical Trials as Topic; Cognition; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; Neuropsychological Tests; Somatostatin; Time Factors | 1999 |
Regulatory effects of cytokines and cyclosporine A on peripheral blood mononuclear cells from stable multiple sclerosis patients.
Topics: Adult; Cyclosporine; Cytokines; Female; Humans; Immunosuppressive Agents; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Multiple Sclerosis; Phytohemagglutinins; Receptors, Interleukin-2; Tetradecanoylphorbol Acetate | 1999 |
Cyclosporin A treatment modulates cytokine mRNA expression by inflammatory cells extracted from the spinal cord of rats with experimental autoimmune encephalomyelitis induced by inoculation with myelin basic protein.
Topics: Actins; Animals; Antifungal Agents; Cell Count; Cyclosporine; Cytokines; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Guinea Pigs; Interferon-gamma; Interleukin-10; Interleukin-2; Interleukin-4; Multiple Sclerosis; Myelin Basic Protein; Myelitis; Polymerase Chain Reaction; Rats; RNA, Messenger; T-Lymphocytes | 2001 |
The effect of immunosuppressive protocols on spontaneous CNS remyelination following toxin-induced demyelination.
Topics: Animals; Cyclophosphamide; Cyclosporine; Demyelinating Diseases; Drug Therapy, Combination; Enzyme Inhibitors; Ethidium; Female; Immunosuppression Therapy; Immunosuppressive Agents; Injections, Subcutaneous; Multiple Sclerosis; Myelin Sheath; Nerve Regeneration; Oligodendroglia; Rats; Rats, Sprague-Dawley; Schwann Cells; Stress, Physiological | 2001 |
Regulation of myelin basic protein-specific helper T cells in multiple sclerosis: generation of suppressor T cell lines.
Topics: Antigens, Differentiation, T-Lymphocyte; CD3 Complex; CD4-Positive T-Lymphocytes; CD8 Antigens; Cells, Cultured; Clone Cells; Cyclosporine; Cytotoxicity, Immunologic; HLA-DR Antigens; Humans; In Vitro Techniques; Lymphocyte Activation; Lymphokines; Multiple Sclerosis; Myelin Basic Protein; Receptors, Antigen, T-Cell; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1992 |
SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effects in
Topics: Animals; Cell Movement; Central Nervous System; Chronic Disease; Cyclosporine; Cyclosporins; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Furans; Immunosuppressive Agents; Lymph Nodes; Lymphocytes; Multiple Sclerosis; Phospholipid Ethers; Rats; Rats, Inbred Lew; Recurrence; Remission Induction | 1992 |